Aggregated Tau Measured by Visual Interpretation of Flortaucipir Positron Emission Tomography and the Associated Risk of Clinical Progression of Mild Cognitive Impairment and Alzheimer Disease: Results From 2 Phase III Clinical Trials

IMPORTANCE: Flortaucipir positron emission tomography (PET) scans, rated with a novel, US Food and Drug Administration–approved, clinically applicable visual interpretation method, provide valuable information regarding near-term clinical progression of patients with Alzheimer disease (AD) or mild c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Neurol
Autors principals: Lu, Ming, Pontecorvo, Michael J., Devous, Michael D., Arora, Anupa K., Galante, Nicholas, McGeehan, Anne, Devadanam, Catherine, Salloway, Stephen P., Doraiswamy, P. Murali, Curtis, Craig, Truocchio, Stephen P., Flitter, Matthew, Locascio, Tricia, Devine, Marybeth, Zimmer, Jennifer A., Fleisher, Adam S., Mintun, Mark A.
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2021
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7885097/
https://ncbi.nlm.nih.gov/pubmed/33587110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2020.5505
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars